Elicio Therapeutics (ELTX) Shareholder's Equity Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.14% |
| Dec 31, 2025 | 114.46% |
| Sep 30, 2025 | 120.10% |
| Jun 30, 2025 | 211.02% |
| Mar 31, 2025 | 82.83% |
| Dec 31, 2024 | -199.46% |
| Sep 30, 2024 | -242.90% |
| Jun 30, 2024 | -107.01% |
| Mar 31, 2024 | 104.43% |
| Dec 31, 2023 | 111.13% |
| Sep 30, 2023 | 113.88% |
| Jun 30, 2023 | 126.58% |
| Mar 31, 2023 | -34.92% |
| Dec 31, 2022 | -37.04% |
| Sep 30, 2022 | -248.34% |
| Jun 30, 2022 | -214.80% |
| Mar 31, 2022 | -188.09% |
| Dec 31, 2021 | 17.59% |
| Sep 30, 2021 | 202.09% |
| Jun 30, 2021 | 257.22% |
| Mar 31, 2021 | 401.35% |